Patents by Inventor Haizhen Zhang

Haizhen Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11214562
    Abstract: A compound of the Formula (1) is below provided where R1-R5 are as described in the description and each “*” represents a chiral center.
    Type: Grant
    Filed: July 17, 2017
    Date of Patent: January 4, 2022
    Assignee: ELI LILLY AND COMPANY
    Inventors: Zhi Long Hu, Lian Zhu Liu, Tianwei Ma, Mi Zeng, Haizhen Zhang
  • Publication number: 20210292302
    Abstract: A compound of the Formula (1) is below provided where R1-R5 are as described in the description and each “*” represents a chiral center.
    Type: Application
    Filed: July 17, 2017
    Publication date: September 23, 2021
    Inventors: Zhi Long Hu, Lian Zhu Liu, Tianwei Ma, Mi Zeng, Haizhen Zhang
  • Patent number: 11117891
    Abstract: The present invention provides a compound of Formula II wherein X is selected from the group consisting of CH and N; Q is selected from the group consisting of CH3 and H; R is selected from the group consisting of and; or a pharmaceutically acceptable salt thereof, compositions, methods to treat liver disease and NASH.
    Type: Grant
    Filed: February 21, 2018
    Date of Patent: September 14, 2021
    Assignee: Eli Lilly and Company
    Inventors: Hui Lei, Gang Liu, Yuan Tian, Haizhen Zhang
  • Publication number: 20200062751
    Abstract: The present invention provides a compound of Formula I I wherein X is selected from the group consisting of CH and N; Q is selected from the group consisting of CH3 and H; R is selected from the group consisting of and; or a pharmaceutically acceptable salt thereof, compositions, methods to treat liver disease and NASH.
    Type: Application
    Filed: February 21, 2018
    Publication date: February 27, 2020
    Inventors: Hui LEI, Gang LIU, Yuan TIAN, Haizhen ZHANG
  • Patent number: 10370352
    Abstract: The present invention provides a compound of Formula I wherein Q is selected from the group consisting of —CH(CH3)2 and R is selected from the group consisting of or a pharmaceutically acceptable salt thereof; compositions, methods to treat liver disease and NASH.
    Type: Grant
    Filed: September 6, 2018
    Date of Patent: August 6, 2019
    Assignee: ELI LILLY AND COMPANY
    Inventors: Lian Zhu Liu, Haizhen Zhang, Xiaoqing Wang, Gang Liu
  • Publication number: 20190071413
    Abstract: The present invention provides a compound of Formula I wherein Q is selected from the group consisting of —CH(CH3)2 and R is selected from the group consisting of or a pharmaceutically acceptable salt thereof; compositions, methods to treat liver disease and NASH.
    Type: Application
    Filed: September 6, 2018
    Publication date: March 7, 2019
    Inventors: Lian Zhu LIU, Haizhen ZHANG, Xiaoqing WANG, Gang LIU
  • Patent number: 10196385
    Abstract: The present invention provides compounds of the Formula below wherein R, R1-R3 are as described herein; methods of treating patients for diabetes using the compounds, and processes for preparing the compounds.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: February 5, 2019
    Assignee: Eli Lilly and Company
    Inventors: Zhi Long Hu, Lian Zhu Liu, Tianwei Ma, Haizhen Zhang, Jingye Zhou
  • Publication number: 20180194755
    Abstract: The present invention provides compounds of the Formula below wherein R, R1-R3 are as described herein; methods of treating patients for diabetes using the compounds, and processes for preparing the compounds
    Type: Application
    Filed: February 19, 2016
    Publication date: July 12, 2018
    Inventors: Zhi Long Hu, Lian Zhu Liu, Tianwei Ma, Haizhen Zhang, Jingye Zhou